Kiniksa Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Kiniksa Pharmaceuticals Stock Summary

Kiniksa Pharmaceuticals competes with Nuvalent, Ventyx Biosciences, Arcellx, Cullinan Oncology, and Day One. Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Kiniksa Pharmaceuticals, Ltd. was incorporated in 2015 and is based in Hamilton, Bermuda. Kiniksa Pharmaceuticals is traded on NASDAQ Exchange in the United States.

Kiniksa Pharmaceuticals Key Financial Ratios

Kiniksa Pharmaceuticals Key Balance Sheet Accounts

Kiniksa Pharmaceuticals Key Income Statement Accounts

Kiniksa Pharmaceuticals Key Cash Accounts

Kiniksa Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kiniksa Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Kiniksa Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kiniksa Pharmaceuticals competition to find correlations between indicators driving Kiniksa Pharmaceuticals's intrinsic value. More Info.Kiniksa Pharmaceuticals is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers . At present, Kiniksa Pharmaceuticals' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kiniksa Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Kiniksa Pharmaceuticals Systematic Risk

Today, most investors in Kiniksa Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Kiniksa Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Kiniksa Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Kiniksa Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kiniksa Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kiniksa Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Kiniksa Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kiniksa Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Kiniksa Pharmaceuticals' price analysis, check to measure Kiniksa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiniksa Pharmaceuticals is operating at the current time. Most of Kiniksa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiniksa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiniksa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiniksa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.